| scholarly article | Q13442814 |
| P2093 | author name string | Wei Luo | |
| Chang Gong | |||
| Shaohua Qu | |||
| Bodu Liu | |||
| Weige Tan | |||
| Gehao Liang | |||
| P2860 | cites work | Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia | Q24539231 |
| Accumulation of miR-155 and BIC RNA in human B cell lymphomas | Q24556523 | ||
| Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma | Q24595213 | ||
| Loss of miR-200 Inhibition of Suz12 Leads to Polycomb-Mediated Repression Required for the Formation and Maintenance of Cancer Stem Cells | Q24610880 | ||
| Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor κB and miR-221 | Q24631381 | ||
| The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 | Q24646996 | ||
| Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression | Q24647373 | ||
| Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells | Q24649127 | ||
| miR-17-92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2/p130 | Q24652820 | ||
| Most mammalian mRNAs are conserved targets of microRNAs | Q24655061 | ||
| MicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT) | Q26853284 | ||
| Origins and Mechanisms of miRNAs and siRNAs | Q27860822 | ||
| Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening | Q45355708 | ||
| Generation of miRNA sponge constructs. | Q45800478 | ||
| Regulation of vascular leak and recovery from ischemic injury by general and VE-cadherin-restricted miRNA antagonists of miR-27. | Q46876808 | ||
| Loss of p21(Sdi1) expression in senescent cells after DNA damage accompanied with increase of miR-93 expression and reduced p53 interaction with p21(Sdi1) gene promoter. | Q53289184 | ||
| [miR-221 mediates epithelial-mesenchymal transition-related gene expressions via regulation of PTEN/Akt signaling in drug-resistant glioma cells]. | Q54373589 | ||
| [Role of let-7 in maintaining characteristics of breast cancer stem cells]. | Q54492842 | ||
| Angiogenesis is controlled by miR-27b associated with endothelial tip cells | Q58214716 | ||
| Differences in islet-enriched miRNAs in healthy and glucose intolerant human subjects | Q60191808 | ||
| Construction of let-7a expression plasmid and its inhibitory effect on k-Ras protein in A549 lung cancer cells | Q82552350 | ||
| Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin | Q83961794 | ||
| [Construction of miRNA sponge targeting miR-20a and stable expression in Jurkat leukemia cell line] | Q85325542 | ||
| MicroRNAs in cancer | Q86065522 | ||
| [Anti-leukemia mechanism of miR-17 and miR-20a silencing mediated by miRNA sponge] | Q87598470 | ||
| The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 | Q27860849 | ||
| Role of microRNAs in plant and animal development | Q28188025 | ||
| The role of let-7 in cell differentiation and cancer | Q28259549 | ||
| The roles of miR-17-92 cluster in mammal development and tumorigenesis | Q28265498 | ||
| miR-17-92 angiogenesis micromanagement | Q28284891 | ||
| Concomitant MYC and microRNA cluster miR-17-92 (C13orf25) amplification in human mantle cell lymphoma | Q28290391 | ||
| let-7 and miR-17-92: small-sized major players in lung cancer development | Q28291431 | ||
| microRNAs as oncogenes and tumor suppressors | Q29619907 | ||
| Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer | Q31022382 | ||
| Using expression profiling data to identify human microRNA targets | Q31137117 | ||
| MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells | Q33497932 | ||
| Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer | Q33654179 | ||
| A microRNA-operated switch of asymmetric-to-symmetric cancer stem cell divisions. | Q33751351 | ||
| SHOX2 is a direct miR-375 target and a novel epithelial-to-mesenchymal transition inducer in breast cancer cells | Q33891236 | ||
| The evolution of controlled multitasked gene networks: the role of introns and other noncoding RNAs in the development of complex organisms | Q34086807 | ||
| Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases. | Q34159409 | ||
| Chemical modification and design of anti-miRNA oligonucleotides. | Q34200255 | ||
| Effective delivery of anti-miRNA DNA oligonucleotides by functionalized gold nanoparticles. | Q34205314 | ||
| Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. | Q34209735 | ||
| Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease? | Q34455538 | ||
| EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells | Q34803710 | ||
| Targeting miR-205 in breast cancer | Q35008487 | ||
| Placenta-specific miRNA (miR-512-3p) targets PPP3R1 encoding the calcineurin B regulatory subunit in BeWo cells | Q35045834 | ||
| Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. | Q35606800 | ||
| LNA-based oligonucleotide electrotransfer for miRNA inhibition | Q36142470 | ||
| Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster, methylation of which is associated with metastasis or hormone receptor status i | Q36250545 | ||
| MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression | Q36498054 | ||
| Downregulation of miR-17~92 Expression Increase Paclitaxel Sensitivity in Human Ovarian Carcinoma SKOV3-TR30 Cells via BIM Instead of PTEN | Q36656142 | ||
| MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells | Q36697933 | ||
| MicroRNAs in metabolic disease | Q37088373 | ||
| Results based on 124 cases of breast cancer and 97 controls from Taiwan suggest that the single nucleotide polymorphism (SNP309) in the MDM2 gene promoter is associated with earlier onset and increased risk of breast cancer | Q37112360 | ||
| Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA. | Q37278413 | ||
| IL-6 upregulation contributes to the reduction of miR-26a expression in hepatocellular carcinoma cells | Q37371336 | ||
| miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer | Q37375623 | ||
| miR-21 as a key regulator of oncogenic processes | Q37554678 | ||
| miR-30 inhibits TGF-β1-induced epithelial-to-mesenchymal transition in hepatocyte by targeting Snail1. | Q39415867 | ||
| P-glycoprotein enhances radiation-induced apoptotic cell death through the regulation of miR-16 and Bcl-2 expressions in hepatocellular carcinoma cells. | Q39588893 | ||
| Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells | Q39601112 | ||
| L-tyrosine-loaded nanoparticles increase the antitumoral activity of direct electric current in a metastatic melanoma cell model | Q39615037 | ||
| Utilizing antagomiR (antisense microRNA) to knock down microRNA in murine bone marrow cells. | Q39738230 | ||
| miR-372 regulates cell cycle and apoptosis of ags human gastric cancer cell line through direct regulation of LATS2. | Q39770962 | ||
| MicroRNAs get to the heart of development | Q42008926 | ||
| Bifunctional oligodeoxynucleotide/antagomiR constructs: evaluation of a new tool for microRNA silencing | Q42240544 | ||
| Clinical significance and the correlation of expression between Let-7 and K-ras in non-small cell lung cancer | Q42263029 | ||
| Curcumin modulates miR-19/PTEN/AKT/p53 axis to suppress bisphenol A-induced MCF-7 breast cancer cell proliferation | Q42705645 | ||
| Epithelial-mesenchymal transition - activating transcription factors - multifunctional regulators in cancer | Q42928789 | ||
| Reply: Comment on 'Beta-blockers increase response to chemotherapy via direct anti-tumour and anti-angiogenic mechanisms in neuroblastoma'--β-blockers are potent anti-angiogenic and chemo-sensitising agents, rather than cytotoxic drugs | Q42957826 | ||
| PNA-based artificial nucleases as antisense and anti-miRNA oligonucleotide agents | Q43642144 | ||
| miR-145 suppresses cell invasion in hepatocellular carcinoma cells: miR-145 targets ADAM17. | Q44055579 | ||
| miR-148b-nanoparticle conjugates for light mediated osteogenesis of human adipose stromal/stem cells | Q44309182 | ||
| Functional microRNAs and target sites are created by lineage-specific transposition | Q37619287 | ||
| A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression. | Q37631219 | ||
| Reexpression of Let-7g microRNA inhibits the proliferation and migration via K-Ras/HMGA2/snail axis in hepatocellular carcinoma | Q37650460 | ||
| Over-expression of miR-98 in FFPE tissues might serve as a valuable source for biomarker discovery in breast cancer patients | Q37676792 | ||
| miR-34 cooperates with p53 in suppression of prostate cancer by joint regulation of stem cell compartment | Q37706146 | ||
| The breast cancer oncogene EMSY represses transcription of antimetastatic microRNA miR-31. | Q37706322 | ||
| Regulation of Myc by miR-34c: A mechanism to prevent genomic instability? | Q37770207 | ||
| Stem cell microRNAs in senescence and immortalization: novel players in cancer therapy | Q37906461 | ||
| MicroRNAs in learning, memory, and neurological diseases | Q38035830 | ||
| High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer | Q38055600 | ||
| Stem cell plasticity in development and cancer: epigenetic origin of cancer stem cells | Q38059676 | ||
| A brief primer on microRNAs and their roles in angiogenesis | Q38074494 | ||
| Targeting translational control as a novel way to treat inflammatory disease: the emerging role of microRNAs | Q38129926 | ||
| Targeting angiogenesis and the tumor microenvironment | Q38135123 | ||
| MicroRNAs and the cancer phenotype: profiling, signatures and clinical implications | Q38174308 | ||
| MicroRNAs: master regulators of drug resistance, stemness, and metastasis. | Q38186568 | ||
| MicroRNAs in vascular aging and atherosclerosis. | Q38200421 | ||
| Strategies to antagonize miRNA functions in vitro and in vivo | Q38285749 | ||
| Design of a miRNA sponge for the miR-17 miRNA family as a therapeutic strategy against vulvar carcinoma. | Q38841725 | ||
| Downregulation of miR-101-3p by hepatitis B virus promotes proliferation and migration of hepatocellular carcinoma cells by targeting Rab5a | Q38999469 | ||
| MiR-324-5p inhibits proliferation of glioma by target regulation of GLI1. | Q39007182 | ||
| c-Myc-mediated repression of miR-15-16 in hypoxia is induced by increased HIF-2α and promotes tumor angiogenesis and metastasis by upregulating FGF2. | Q39007411 | ||
| MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer. | Q39010477 | ||
| Effect of CDH1 gene methylation on transforming growth factor (TGF-β)-induced epithelial-mesenchymal transition in alveolar epithelial cell line A549. | Q39016736 | ||
| β1 integrin inhibition elicits a prometastatic switch through the TGFβ-miR-200-ZEB network in E-cadherin-positive triple-negative breast cancer. | Q39024860 | ||
| The role of viral and host microRNAs in the Aujeszky's disease virus during the infection process | Q39029366 | ||
| Serum-resistant complex nanoparticles functionalized with imidazole-rich polypeptide for gene delivery to pulmonary metastatic melanoma | Q39039581 | ||
| MiR-25 promotes gastric cancer cells growth and motility by targeting RECK. | Q39090032 | ||
| Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state | Q39176448 | ||
| MicroRNA profiling can classify acute leukemias of ambiguous lineage as either acute myeloid leukemia or acute lymphoid leukemia | Q39187984 | ||
| MicroRNA let-7a inhibits the proliferation and invasion of nonsmall cell lung cancer cell line 95D by regulating K-Ras and HMGA2 gene expression | Q39248357 | ||
| MiR-195 regulates cell apoptosis of human hepatocellular carcinoma cells by targeting LATS2. | Q39298516 | ||
| MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma | Q39376558 | ||
| MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms | Q39389208 | ||
| miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer | Q39403567 | ||
| P433 | issue | 3 | |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 2735-2742 | |
| P577 | publication date | 2017-12-19 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | MicroRNAs and cancer: Key paradigms in molecular therapy | |
| P478 | volume | 15 |
| Q93059595 | Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer |
| Q96303080 | Circular RNA circUBAP2 regulates proliferation and invasion of osteosarcoma cells through miR-641/YAP1 axis |
| Q94552561 | Comprehensive analysis of the long non-coding RNA-associated competitive endogenous RNA network reveals novel prognostic biomarkers in Wilms' tumor |
| Q64992388 | Functional Effects of let-7g Expression in Colon Cancer Metastasis. |
| Q90163228 | Gene Therapy in Cancer Treatment: Why Go Nano? |
| Q92861817 | Helicobacter pylori Dampens HLA-II Expression on Macrophages via the Up-Regulation of miRNAs Targeting CIITA |
| Q64997598 | High Glucose Concentrations Negatively Regulate the IGF1R/Src/ERK Axis through the MicroRNA-9 in Colorectal Cancer. |
| Q93108873 | Hypoxia-Inducible Factors as an Alternative Source of Treatment Strategy for Cancer |
| Q64099500 | Involvement of miR-770-5p in trastuzumab response in HER2 positive breast cancer cells |
| Q92187262 | MiR-566 mediates cell migration and invasion in colon cancer cells by direct targeting of PSKH1 |
| Q92798978 | MicroRNA 145 enhances chemosensitivity of glioblastoma stem cells to demethoxycurcumin |
| Q90079974 | MicroRNA Networks Modulate Oxidative Stress in Cancer |
| Q90706208 | MicroRNA-155-3p promotes glioma progression and temozolomide resistance by targeting Six1 |
| Q90613540 | MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer |
| Q93005381 | Mining Featured Biomarkers Linked with Epithelial Ovarian CancerBased on Bioinformatics |
| Q91652631 | Overexpression of microRNA-145 inhibits tumorigenesis through autophagy in chemotherapy and radiation resistant neuroblastoma cells |
| Q64269751 | Prognostic significance of deregulated microRNAs in uveal melanomas |
| Q59133908 | Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer |
| Q59136865 | Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals |
| Q90568606 | The Regulatory Role of MicroRNAs in Breast Cancer |
| Q58797073 | Upregulated hsa_circ_0004458 Contributes to Progression of Papillary Thyroid Carcinoma by Inhibition of miR-885-5p and Activation of RAC1 |
| Q92738337 | Upregulated microRNA‑671‑3p promotes tumor progression by suppressing forkhead box P2 expression in non‑small‑cell lung cancer |
| Q95261601 | miR-30a-3p inhibits renal cancer cell invasion and metastasis through targeting ATG12 |
| Q93046978 | microRNA Crosstalk Influences Epithelial-to-Mesenchymal, Endothelial-to-Mesenchymal, and Macrophage-to-Mesenchymal Transitions in the Kidney |
Search more.